Ignite Creation Date:
2024-05-05 @ 10:14 PM
Last Modification Date:
2024-10-26 @ 10:16 AM
Study NCT ID:
NCT01065753
Status:
COMPLETED
Last Update Posted:
2010-02-09
First Post:
2010-02-08
Brief Title:
Multi-faceted Evaluations Following Weight Reduction in Subjects With Metabolic Syndrome
Sponsor:
Taichung Veterans General Hospital
Organization:
Taichung Veterans General Hospital
Study Overview
Official Title:
Study of Wight Reduction by Life-style Modification
Status:
COMPLETED
Status Verified Date:
2009-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Central obesity core of metabolic syndrome has been recognized as one of the rooting factors for development of diabetes and cardiovascular disease Although efforts have been devoted to the studies of central obesity andor metabolic syndrome much remained unknown as to how obesity influences cellular as well as cardiac functions what is the central regulation of ones body weight
Weight loss is an undisputed way to improve cardiovascular and metabolic disorders in obese individuals Previous studies have demonstrated that weight loss by 5 of initial weight universally provide substantial benefits in these subjects However there are little integrated research teams composed of different disciplines share common weight reduction program to look at different aspects of weight reduction in non-diabetic individuals with metabolic syndrome The significances of this proposal we plan to target namely Rho kinase activity from peripheral leukocyte several cardiac functions measured by noninvasive technique VP-2000 and MRI circulating brain-derived neurotrophic factors BDNF levels are fully explained detailed in each sub-proposal
In order to accomplish this integrated proposal we will form research teams including endocrinologists cardiologists radiologists and a coordinating data center We pan to recruit 40 non-diabetic individuals with metabolic syndrome to participate this 12-16 weeks weight reduction program Twenty-five age sex matched non-diabetes lean will be served as controls Oral glucose tolerance test fasting blood obtained noninvasive vascular and MRI examinations will be applied before and after weight reduction program in those achieving at least 5 loss of initial weight
In summary this study will investigate the effects of weight loss on 1 Rho kinase activity obtained from peripheral leukocyte 2 Aortic stiffness central aortic pressure and hemodynamic by a noninvasive vascular profiling system VP-2000 3 Brain function specifically reflecting by circulating BDNF 4 Aortic elastic properties and left ventricular function by using MRI examinations in non-diabetic individuals of metabolic syndrome
Weight loss is an undisputed way to improve cardiovascular and metabolic disorders in obese individuals Previous studies have demonstrated that weight loss by 5 of initial weight universally provide substantial benefits in these subjects However there are little integrated research teams composed of different disciplines share common weight reduction program to look at different aspects of weight reduction in non-diabetic individuals with metabolic syndrome The significances of this proposal we plan to target namely Rho kinase activity from peripheral leukocyte several cardiac functions measured by noninvasive technique VP-2000 and MRI circulating brain-derived neurotrophic factors BDNF levels are fully explained detailed in each sub-proposal
In order to accomplish this integrated proposal we will form research teams including endocrinologists cardiologists radiologists and a coordinating data center We pan to recruit 40 non-diabetic individuals with metabolic syndrome to participate this 12-16 weeks weight reduction program Twenty-five age sex matched non-diabetes lean will be served as controls Oral glucose tolerance test fasting blood obtained noninvasive vascular and MRI examinations will be applied before and after weight reduction program in those achieving at least 5 loss of initial weight
In summary this study will investigate the effects of weight loss on 1 Rho kinase activity obtained from peripheral leukocyte 2 Aortic stiffness central aortic pressure and hemodynamic by a noninvasive vascular profiling system VP-2000 3 Brain function specifically reflecting by circulating BDNF 4 Aortic elastic properties and left ventricular function by using MRI examinations in non-diabetic individuals of metabolic syndrome
Detailed Description:
Obesity in particular central obesity has been one of the important documented risk factors for development of diabetes and cardiovascular disease Recent re-delineated various versions of definitions of metabolic syndrome has fueled further the critical involvement of central adiposity in these disorders through several facets including many increased circulating pro-inflammatory cytokines directly or indirectly linking to visceral adipose tissue expressions Although lots of efforts have been devoted to the studies of central obesity andor metabolic syndrome much remained unknown as to how obesity affect cellular as well as cardiac function what is the central regulation of ones body weight and how to measure fat in visceral organs precisely
Weight loss is an undisputed way to improve cardiovascular and metabolic disorders Both a recent review article and data from us demonstrated that only weight loss by 5 of initial weight universally delivered benefits on obese individuals However there is little integrated research teams from different disciplines share common weight reduction protocol and look at different aspects of weight reduction in non-diabetic individuals with metabolic syndrome The significances of this proposal we plan to target are explained in detail in each sub-proposal However we would like to make a briefing description here
1 Rho kinase ROCK is a serinethreonine kinase that mediates the downstream signaling of the small guanosine triphosphate- binding protein Rho on the actin cytoskeleton In mostly animal models the inhibition of ROCK ameliorates many cardiovascular conditions including hypertension atherosclerosis myocardial fibrosis and stroke Recent study from Taiwan showed that ROCK activity is increased in patients with metabolic syndrome
2 Obese and overweight individuals have increased levels of arterial stiffness which is a measure of aortic and large vessel distensibility or compliance Weight loss could induce significant reduction in sympathetic activity and blood pressure However little is known as whether weight loss can improve arterial stiffness central aortic blood pressure and related hemodynamics
3 Brain-derived neurotrophic factor BDNF recently reported related to Alzheimers disease is present in brain tissues extensively It is also noted that low circulating level of BDNF was associated with impaired glucose metabolism and might be associated higher BMI or body fat We are interesting in effect of weight reduction on circulating BDNF values in non-diabetic subjects with metabolic syndrome
4 Magnetic resonance imaging MRI of the heart is frequently used and can provide accurate and reproducible measurement of LV mass volumes systolic function and aortic pulse velocity Although echo-cardiography has been applied to study effect of weight loss on cardiac function there has been no study by using cardiac MRI to measure cine images of cardiac function and related variables before and after weight reduction in non-diabetic subjects with metabolic syndrome
In order to accomplish this integrated proposal we will formulate research teams including endocrinologists cardiologists radiologists and a data center coordinated by a PhD researcher infra-structure as described below We will recruit 40 non-diabetic individuals with metabolic syndrome fulfilled the criteria from IDF 2006 and DOH of Taiwan Twenty-five age sex matched non-diabetes lean will be served as controls
Written informed consent will be obtained from each subject before being enrolled into the study after approval from IRB of Taichung VGH Taichung Taiwan This weight reduction program will be assisted by experienced dieticians and sports experts all of whom we had collaborated and published article previously This program will last for 12-16 weeks with every participants join together courses 4 hours per week Each participant will be introduced a dietary plan based on a caloric reduction of 1200 Kcalday from the values thought necessary to maintain their usual weight Subject will be asked to follow dietary advice and their eating habit will be reviewed by dietician at the time of their weekly visit Activity levels will be encouraged to reach 30 min each day and at least 5 days a week During each visit weight of each participant will be recorded and announced Meals replacement may considered for those did not get much improvement during weekly monitoring since recent report indicated that meals replacement may provide certain help in reducing body weight We are confident that adequate weight reduction at least 5 of initial weight and good compliance will be achieved given our previous experience
In aggregate this study will investigate the effects of weight loss on 1 Rho kinase activity obtained from peripheral leukocyte 2 Aortic stiffness central aortic pressure and hemodynamic by a noninvasive technique 3 Brain function specifically reflecting by circulating BDNF levels 4 Aortic elastic properties and left ventricular function by using MRI examinations in non-diabetic individuals of metabolic syndrome Findings from this integrated proposal will provide valuable information as mild to moderate weight loss 5 of initial body weight in cellular cardiac and central nervous system in additional to well-known effects on lipids inflammatory cytokines and insulin resistance in non-diabetic subjects with metabolic syndrome
Follow up- Subjects received physical check up fasting blood tests and OGTT 6 and 12 months after the end of study
Weight loss is an undisputed way to improve cardiovascular and metabolic disorders Both a recent review article and data from us demonstrated that only weight loss by 5 of initial weight universally delivered benefits on obese individuals However there is little integrated research teams from different disciplines share common weight reduction protocol and look at different aspects of weight reduction in non-diabetic individuals with metabolic syndrome The significances of this proposal we plan to target are explained in detail in each sub-proposal However we would like to make a briefing description here
1 Rho kinase ROCK is a serinethreonine kinase that mediates the downstream signaling of the small guanosine triphosphate- binding protein Rho on the actin cytoskeleton In mostly animal models the inhibition of ROCK ameliorates many cardiovascular conditions including hypertension atherosclerosis myocardial fibrosis and stroke Recent study from Taiwan showed that ROCK activity is increased in patients with metabolic syndrome
2 Obese and overweight individuals have increased levels of arterial stiffness which is a measure of aortic and large vessel distensibility or compliance Weight loss could induce significant reduction in sympathetic activity and blood pressure However little is known as whether weight loss can improve arterial stiffness central aortic blood pressure and related hemodynamics
3 Brain-derived neurotrophic factor BDNF recently reported related to Alzheimers disease is present in brain tissues extensively It is also noted that low circulating level of BDNF was associated with impaired glucose metabolism and might be associated higher BMI or body fat We are interesting in effect of weight reduction on circulating BDNF values in non-diabetic subjects with metabolic syndrome
4 Magnetic resonance imaging MRI of the heart is frequently used and can provide accurate and reproducible measurement of LV mass volumes systolic function and aortic pulse velocity Although echo-cardiography has been applied to study effect of weight loss on cardiac function there has been no study by using cardiac MRI to measure cine images of cardiac function and related variables before and after weight reduction in non-diabetic subjects with metabolic syndrome
In order to accomplish this integrated proposal we will formulate research teams including endocrinologists cardiologists radiologists and a data center coordinated by a PhD researcher infra-structure as described below We will recruit 40 non-diabetic individuals with metabolic syndrome fulfilled the criteria from IDF 2006 and DOH of Taiwan Twenty-five age sex matched non-diabetes lean will be served as controls
Written informed consent will be obtained from each subject before being enrolled into the study after approval from IRB of Taichung VGH Taichung Taiwan This weight reduction program will be assisted by experienced dieticians and sports experts all of whom we had collaborated and published article previously This program will last for 12-16 weeks with every participants join together courses 4 hours per week Each participant will be introduced a dietary plan based on a caloric reduction of 1200 Kcalday from the values thought necessary to maintain their usual weight Subject will be asked to follow dietary advice and their eating habit will be reviewed by dietician at the time of their weekly visit Activity levels will be encouraged to reach 30 min each day and at least 5 days a week During each visit weight of each participant will be recorded and announced Meals replacement may considered for those did not get much improvement during weekly monitoring since recent report indicated that meals replacement may provide certain help in reducing body weight We are confident that adequate weight reduction at least 5 of initial weight and good compliance will be achieved given our previous experience
In aggregate this study will investigate the effects of weight loss on 1 Rho kinase activity obtained from peripheral leukocyte 2 Aortic stiffness central aortic pressure and hemodynamic by a noninvasive technique 3 Brain function specifically reflecting by circulating BDNF levels 4 Aortic elastic properties and left ventricular function by using MRI examinations in non-diabetic individuals of metabolic syndrome Findings from this integrated proposal will provide valuable information as mild to moderate weight loss 5 of initial body weight in cellular cardiac and central nervous system in additional to well-known effects on lipids inflammatory cytokines and insulin resistance in non-diabetic subjects with metabolic syndrome
Follow up- Subjects received physical check up fasting blood tests and OGTT 6 and 12 months after the end of study
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None